[
  {
    "ts": null,
    "headline": "Intellia Gains 29.8% in a Month: How Should You Play the Stock?",
    "summary": "NTLA stock surges 29.8% in a month, driven by gene therapy pipeline progress and growing investor attention.",
    "url": "https://finnhub.io/api/news?id=6386b7f23af3aa0e49534700ec1d95176e97cbb4a803c19ee3fecc9a8c7d56d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751895960,
      "headline": "Intellia Gains 29.8% in a Month: How Should You Play the Stock?",
      "id": 135786795,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "NTLA stock surges 29.8% in a month, driven by gene therapy pipeline progress and growing investor attention.",
      "url": "https://finnhub.io/api/news?id=6386b7f23af3aa0e49534700ec1d95176e97cbb4a803c19ee3fecc9a8c7d56d2"
    }
  },
  {
    "ts": null,
    "headline": "Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs",
    "summary": "An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide (https://ibn.fm/dyQrw) with these numbers expected to grow. The American Cancer Society projects that by 2050, 35 million people will be diagnosed with cancer every year. Despite significant progress made in treating the disease, there is still a desperate need — and an enormous market potential — for new and more effective cancer drugs. Calidi Biotherapeutics Inc. (NYS",
    "url": "https://finnhub.io/api/news?id=9996e35d3cc9927ec122d98def2210832f9bd5e20cc4be5e0d3a839db0d55720",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751891400,
      "headline": "Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs",
      "id": 135786796,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide (https://ibn.fm/dyQrw) with these numbers expected to grow. The American Cancer Society projects that by 2050, 35 million people will be diagnosed with cancer every year. Despite significant progress made in treating the disease, there is still a desperate need — and an enormous market potential — for new and more effective cancer drugs. Calidi Biotherapeutics Inc. (NYS",
      "url": "https://finnhub.io/api/news?id=9996e35d3cc9927ec122d98def2210832f9bd5e20cc4be5e0d3a839db0d55720"
    }
  },
  {
    "ts": null,
    "headline": "Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst",
    "summary": "Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst",
    "url": "https://finnhub.io/api/news?id=f54b13cdcabc50355df3fb992ed79d1a5e418ef4bba5284befa0d1ce7ef3d51c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751882466,
      "headline": "Watch Milestone Pharmaceuticals For (Likely) Upcoming FDA Approval For Cardamyst",
      "id": 135786053,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f54b13cdcabc50355df3fb992ed79d1a5e418ef4bba5284befa0d1ce7ef3d51c"
    }
  }
]